Calcitonin gene-related peptide and adrenomedullin are both members of a structurally related neuropeptide family. Both are potent vasodilators and known to be expressed in the trigeminovascular system. Central to functional binding of these neuropeptides is calcitonin receptor-like receptor (CRLR), a G-protein coupled receptor whose cell surface expression and pharmacology is determined by co-expression of a receptor activity-modifying protein (RAMP). CRLR combined with RAMP1 binds CGRP with high affinity, whilst CRLR coexpression with either RAMP2 or RAMP3 confers high affinity binding of adrenomedullin. We sought to investigate expression of these receptor components in human cerebral and cranial vasculature to further characterize CGRP receptor family content and potential function(s) in this vascular system. Antisera specific for CRLR, RAMP1, RAMP2, and RAMP3 were raised, characterized, and applied to tissue sections utilizing modern immunohistochemical techniques and confocal microscopy. Localization data demonstrated for the first time, the presence of these receptor component proteins in human cerebrovasculature, and suggest that both CGRP and adrenomedullin receptors may arise from coassembly of these accessory proteins with CRLR. These novel data advance our understanding of the function of the trigeminovascular system and the normal and potential pathophysiological role of CGRP family neuropeptides.
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